NCT06824324View on ClinicalTrials.gov

The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

November 4, 2024

Study Completion Date

January 6, 2025

Conditions
Myofacial Pain Syndrome
Interventions
DRUG

intramuscular Botulinum Toxin

A thirty units of Botulinum toxin A was injected intramuscularly in Triger zone of patient with myofascial pain syndrome

Trial Locations (1)

Unknown

College Of Dentistry University Of Baghdad, Baghdad

All Listed Sponsors
lead

Yassir R. Al-khannaq

OTHER

NCT06824324 - The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome | Biotech Hunter | Biotech Hunter